Revolution Medicines
The Executive Director, Portfolio Systems & Strategy Integration leads the development and evolution of portfolio systems and intelligence capabilities at Revolution Medicines. This role ensures leadership has integrated data, insights, and decision infrastructure to evaluate strategic trade-offs and make high-quality portfolio decisions. The position serves as a strategic partner to the Head of PLPS, driving cross-portfolio strategy projects and optimizing portfolio management processes.
Headquarters
Redwood City, California, United States
Company Size
201-500 employees
Founded
2014
Revolution Medicines (RevMed) is a biopharmaceutical company dedicated to discovering, developing, and delivering novel targeted medicines for patients with cancer. Their mission focuses specifically on "revolutionizing treatment for patients with RAS‑addicted cancers" through precision-targeted therapies. The company emphasizes a science-driven, end-to-end approach from discovery to delivery. RevMed brands its team as "Revolutionaries" committed to transforming outcomes for people with RAS‑driven tumors.
Victory Capital Management Inc. Trims Stock Holdings in Revolution Medicines, Inc. $RVMD
13 hours ago
Revolution Medicines Trials, Funding Capacity And Insider Moves Shape Risk Outlook
5 days ago
Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Revolution Medicines.
Revolution Medicines, Inc. (RVMD) Net Loss Widens amid Progress on Clinical Trial Programs
1 week ago
Senior Manager, Strategy and Portfolio Management, Personal Investor
The Vanguard Group, Inc.
ED, Strategy Prioritization & Governance Lead
Novartis
Vice President, Head of Portfolio & Program Strategy
Umoja Biopharma
Senior Director, HIV Treatment Portfolio Strategy
Gilead Sciences
Sr Manager, Event Portfolio Strategy
SalesForce1 Inc
Associate, Portfolio Strategy & Analytics (Contract) - SLC Management
Sun Life